• Profile
Close

Raynaud's phenomenon- How to treat?

M3 India Newsdesk Dec 24, 2021

Raynaud's phenomenon is a common clinical symptom caused by an exaggerated vascular response to triggers like cold. Out of the two types of Raynaud's phenomenon, namely primary and secondary, the latter needs more attention. Proper clinical history, laboratory diagnosis and imaging can help clinicians in looking for the underlying causes.


What is Raynaud's phenomenon?

Raynaud's phenomenon is an exaggerated vascular response of the arterial circulation triggered by cold ambient temperature and emotional stress.

It is characterised by colour change i.e white (paleness - due to arterial vasospasm) → blue (cyanosis - due to deoxygenated blood or sluggish blood flow) → pink (reactive hyperaemia - restoration of blood supply).

  1. Site- It is most frequently seen in the tips of fingers/toes. It can also be seen in the tip of the nose, ear lobule, tongue, and conjunctiva.
  2. Prevalence- It is common in the general population ranging from 3 to 15% and is more commonly seen in females than males.
  3. Classification- It can be classified into primary and secondary types. It is very important to differentiate between the two as the management approach and pharmacological measures greatly vary for both types.

Primary Raynaud’s phenomenon

It is defined as a recurrent vasospastic event in the absence of any identifiable aetiology and usually has a benign course. It is more common in young females. The condition can be managed easily by lifestyle modification and non-pharmacological measures.

Characteristic features:

  1. Its prevalence is very common.
  2. The onset of the condition is at a young age (<20 years). 
  3. The severity of the condition can be mild to moderate.
  4. There is a symmetric manifestation of symptoms seen.
  5. The condition is not associated with any complications like digital ulcer or gangrene.
  6. There is no negative antinuclear antibody observed.
  7. No nail fold capillaroscopy changes can be seen in this type.

Secondary Raynaud's phenomenon

It is defined as recurrent vasospastic events secondary to various aetiologies. It can be the first manifestation of underlying connective tissue disorder.

Secondary Raynaud’s has a higher propensity to develop complications like digital ulcers or gangrene. Hence it requires active vigilance, education, and non-pharmacological and pharmacological measures. 

Common causes of secondary Raynaud’s phenomenon are:

  1. Autoimmune disorders such as systemic sclerosis (most common), systemic lupus erythematosus, mixed connective tissue disease, Sjogren’s syndrome and idiopathic inflammatory myositis.
  2. Occupational trauma can also be a cause.
  3. Anti-migraine drugs like Ergotamine and its derivative, amphetamines, beta-blockers (non-specific), chemotherapeutic agents like bleomycin and cisplatin.
  4. Haematological conditions like cryoglobulinemia, paraproteinemia, POEMS syndrome, myeloproliferative disorders etc. and obstructive vascular diseases like thoracic outlet syndrome, and atherosclerotic disorders can also lead to the condition.

Characteristic features of secondary Raynaud's phenomenon:

  1. It is a less common condition.
  2. The onset of the condition is at an older age (>30 years).
  3. There is an asymmetric symptom manifestation seen.
  4. Painful attacks are observed where the severity and intensity increases with attacks.
  5. The condition is usually associated with complications like digital ulcer or gangrene, sclerodactyly.
  6. Positive antinuclear antibodies and other disease-specific autoantibodies are observed.
  7. Significant nail fold capillaroscopy changes are present.

Raynaud’s phenomenon can be the initial manifestation of systemic sclerosis. The condition with positive antinuclear antibody and nail fold capillaroscopy have more than 90% chances of developing systemic sclerosis over two years.


Approach to patients with Raynaud’s phenomenon

The clinical history of the patient should include the following:

  • Age, gender, symmetry of presentation, frequency of episodes, the severity of the episode, and complications
  • Any history that may be suggestive of connective tissue disorder - e.g skin thickening, joint pain, skin rash, painless oral or palatal ulcers, oral or ocular sicca symptoms, persistent prolonged dry cough, significant weight loss etc
  • Drug history
  • Associated comorbidities like hypothyroidism, and haematological malignancies

Laboratory analysis should include the following:

  1. If suspecting connective tissue disorder: Complete blood count, peripheral smear, blood chemistry for renal and liver function, urinalysis, antinuclear antibody, rheumatoid factor, disease-specific antibodies, serum complements C3 & C4.
  2. If suspecting haematological malignancy: Peripheral smear, serum protein electrophoresis, serum cryoglobulins, serum-free light chain assay etc.

Radiological imaging- If suspecting obstructive pathology, consider doing an ultrasound colour doppler study of upper limb vessels or if required CT or MR angiogram.

Nail fold capillaroscopy- This is to look for changes in capillary structures like giant or dilated capillaries, micro or macro haemorrhage, dropouts, avascular areas, neoangiogenesis.


Management of Raynaud’s phenomenon

  1. Goals
    1. To improve the quality of life.
    2. To prevent secondary complications.
    3. To follow and observe for the development of features of connective tissue disorder like systemic sclerosis for early diagnosis and treatment.
  2. Non-pharmacological measures- It is a very essential component of effective management which includes:
    1. Patient education: To explain causes, read alarming symptoms and also treatment strategy.
    2. Cold protection:
      1. The most important way of prevention is to maintain a warm ambient temperature and avoid rapid transitioning of warm to cold temperature. To use loose and multilayered clothes to maintain warm core body temperature.
      2. Usage of woollen gloves and avoiding cold weather.
  3. Lifestyle modification
    1. Smoking and drugs that can precipitate Raynaud’s condition should be avoided. 
    2. It is important to reduce and avoid emotional stress.
  4. Pharmacological measures- Usage of oral or systemic vasodilator

Drugs used for managing the condition include:

  • Dihydropyridine calcium channel blocker- First line, e.g. amlodipine, nifedipine etc.
  • Phosphodiesterase 5 inhibitors- Sildenafil, tadalafil
  • Oral and intravenous prostaglandin analogue (prostacyclin) such as alprostadil, Iloprost, epoprostenol etc.
  • Endothelin receptor antagonist- Bosentan and ambrisentan

Other treatment options include:

  • Oral or topical nitroglycerine
  • Nitric oxide enhancer- Cilostazol, serotonin uptake blocker like fluoxetin
  • In refractory cases- Botulinum injection or sympathectomy can be tried

When to start pharmacological treatment?

Although primary Raynaud’s condition can be managed majorly with non-pharmacological measures, those patients whose quality of life is impacted or have moderate to severe intensity warrant a pharmacological measure. Pharmacological treatment can be considered when:

  1. Patients are at risk of developing complications.
  2. Patients have already developed complications like chronic digital ulcers or gangrene.
  3. Patients present with severe Raynaud’s and associated complications.

Disclaimer- The views and opinions expressed in this article are those of the author's and do not necessarily reflect the official policy or position of M3 India.

The author is a practising Rheumatologist from Bangalore.

Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay